Severe pulmonary hypertension is one of the fetal com- 
Introduction
It has been reported that pulmonary hypertension (PH) is associated with various connective tissue diseases (CTD), such as scleroderma (1) , mixed connective tissue disease (2) , CREST (calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia) syndrome (3), systemic lupus erythematosus (SLE) (4) and rheumatoid arthritis (5) . Although there is frequently pulmonary involvement in primary Sjogren's syndrome (SS), such as interstitial fibrosis, tracheobronchial sicca, lymphoma, amyloidosis, pleurisy (6) or bronchial hyperresponsiveness (7) , PH associated with SS has rarely been reported in the English language literature (8) (9) (10) (11) (12) (13) (14) . We describe a case of severe PH, resembling primary pulmonary hypertension (PPH), associated with primary SS and the microscopic findings of a lung biopsy. Moreover, recovery from PH with steroid therapy was observed in this case.
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Case Report
A 42-year-old woman was diagnosed in 1995 with primary SS on the basis of oral sicca symptoms, hypergammaglobulinemia, positive antibodies to Ro (SS-A), and findings of ocular, oral and salivary test. Shilmer's test (right eye, 7 mm/5 min; left eye, 3 mm/5 min), Rose-Bengal test, and chewing gum test (2 ml/10 min) were all positive, and although no labial salivary gland biopsy was carried out, the sialography demonstrated chronic sialoadenitis. After a three-year follow-up at a local hospital, she was admitted to Asahikawa Medical College Hospital because of progressive dyspnea in 1998. On clinical examination, blood pressure was 90/60 mmHg and pulse rate was 60 bpm and regular. Cardiovascular examination showed slight distension of jugular vein, a systolic murmur of grade II/VI in the left parasternal area and narrow splitting of second heart sound. Raynaud' s phenomenon, photosensitivity, butterfly and discoid eruption, Gottron's sign, sclerodactyly, hypodynamia, arthritis, and On laboratory examination, white blood cell count and platelet count were decreased to 2,950/jul and ll.OxlOVjul, respectively. Gammaglobulin and immunoglobulin G (IgG) were increased to 3. After one month of treatment with prednisolone (50 mg/ day), there was improvement of dyspnea and reduction in the size of the right ventricle was observed in the echocardiogram (Fig. IB, D, F) . Gammaglobulin and IgG levels fell to 1.7 g/dl and 1,860 mg/dl, respectively. The patient was discharged in June 1998, and the PH was treated with prednisolone (40 mg/day), prostacyclin and warfarin for one month. After further treatment with prednisolone (30 mg/ day) for two months, she had no complaints of dyspnea and right heart catheterization showed a marked improvement in pulmonary artery pressure (Table  1 ).
Discussion
It is well known that the prognosis for patients with CTD complicated severe PH is miserable and no curative treatment is available (16, 17) . Sato et al reported two cases of SS associated with PH where histopathological information was available (10). They detected the intimal concentric fibrocellular proliferation, medial hypertrophy and plexiform lesion. They also detected depositions of IgG, Clq, C3, C4, and C5 in the pulmonary arterial wall, suggesting an immune complexmediated injury. In the present case, there were depositions of IgM, A, and Clq in the pulmonary arterial wall, but there was no IgG, C3, or C4. In addition, there have been reports of the presence of antinuclear antibody and rheumatoid factor in the wall of pulmonary vessels in two patients with PH to SLE. Other reports showed that immunoglobulins and complement fraction deposition in the pulmonary arterial wall in various CTD with PH (9, (26) (27) (28) The mechanism of immune deposition in pulmonary vessels has never been revealed in CTD. In the present case, the initial components of the classical pathway of complements were found in the similar parts of the pulmonary vesicles similar to those in previous reports (9, 10, 26) . This observation suggests that an antigen in the pulmonary artery may induce activation of the classical complement pathway. On theother hand, it has been reported that immune deposits in the pulmonary vessels resemble those observed in renal glomeruli in patients with SLE. Such immune deposits in the pulmonary vessels have also been observed in patients without PH (27), so it is unlikely that PH is the cause of the immune deposits in the pulmonary vessels. It is possible that immune deposits may be produced through non-immunological mechanisms. However, there is still no evidence that the presence of such deposits in the pulmonary artery is a risk factor in patients with CTD unaffected by PH. The relationship between immune deposition and involvement of pulmonary vessels in the present case is puzzling and there might be an unknown pathogenesis in PH. Although we know that there are many unpublished cases which were not sensitive to immunosuppressive therapy, dramatic improvement has occurred in patients with PH secondary to CTD following steroid therapy similar to the present case (13, 28 therapy in this context because of the lack of a control study (17) . While, immunosuppressive agents have been implicated in adverse effects including severe infections. However, it will be valuable to discuss the possibility of the effectiveness of this therapy in each case now that there are several reports of successful outcome.
In conclusion, endothelial injury due to the deposition of immune complexes may play an important role in PH, and the reversibility of PH with corticosteroids may suggest that an immunological disorder is related to the mechanisms of PH associated with SS.
